Ineffective Tissue Perfusion and Hypertension Study Notes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/34

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:56 PM on 6/14/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

35 Terms

1
New cards

Peripheral Vascular Disease (PVD)

Refers to any disease state affecting the blood vessels located within the extremities.

2
New cards

Atherosclerosis

The most common cause of PVD, characterized by the buildup of cholesterol and lipids along the vessel walls.

3
New cards

Risk Factors for PVD

Includes family history of vascular disease, obesity, sedentary lifestyle, smoking, diabetes, high cholesterol levels, and hypertension.

4
New cards

Peripheral Arterial Disease (PAD)

A specific form of PVD involving the narrowing of the arteries, leading to reduced blood flow to distal extremities.

5
New cards

Intermittent Claudication

The hallmark early sign of PAD, characterized by reproducible ischemic muscle pain during activity, relieved by rest.

6
New cards

Six P’s of PAD

Includes Pain, Paresthesia, Pallor, Pulselessness, Paralysis, and Poikilothermia.

7
New cards

Chronic Venous Insufficiency

Occurs when the venous wall and/or valves in the leg veins do not function effectively, making it difficult for blood to return to the heart.

8
New cards

Manifestations of Chronic Venous Insufficiency

Includes edema, venous stasis ulcers, altered pigmentation, temperature changes, pulse palpability, skin texture changes, and sensation issues.

9
New cards

Arterial Characteristics

Includes intermittent claudication, absent edema, weak or absent pulses, round smooth sores, necrosis, and cool skin temperature.

10
New cards

Venous Characteristics

Includes dull, achy pain, present edema, palpable pulses, drainage from sores, irregular sores, yellow slough or ruddy skin.

11
New cards

Diagnostic Tools for PVD

Includes ultrasound, Ankle Brachial Index (ABI), CT angiography (CTA), angiography, MR angiography (MRA), and contrast phlebography.

12
New cards

Nursing Assessment for PVD

Includes palpation of pulses, health history collection, skin assessment, edema assessment, and monitoring lab values.

13
New cards

Nursing Interventions for PVD

Includes positioning, activity encouragement, thermoregulation, pharmacology, and careful wound and leg care.

14
New cards

Raynaud’s Phenomenon

Characterized by intermittent arterial constriction of small blood vessels, leading to color changes and numbness, triggered by cold or stress.

15
New cards

Deep Vein Thrombosis (DVT)

The formation of a blood clot within a deep vein of an extremity, typically the legs.

16
New cards

Virchow’s Triad

High-risk factors for DVT: endothelial damage, venous stasis, and altered coagulation.

17
New cards

Heparin

Administered as a continuous IV infusion requiring monitoring of aPTT levels.

18
New cards

Warfarin

Administered PO during the heparin infusion; requires INR monitoring.

19
New cards

Hypertension (HTN)

Elevation of blood pressure greater than normal limits, categorized into essential, secondary, white coat, malignant, and pregnancy-induced HTN.

20
New cards

The 4 C’s of Complications of HTN

Includes Coronary Artery Disease (CAD), Congestive Heart Failure (CHF), Cerebral Vascular Accident (CVA), and Chronic Renal Failure (CRF).

21
New cards

DASH Diet

A dietary approach to stop hypertension, emphasizing low sodium intake.

22
New cards

Initial Therapy for HTN

Typically starts with a Thiazide diuretic.

23
New cards

RAAS Pathway

Renin acts on Angiotensinogen to create Angiotensin I, converted to Angiotensin II in the lungs, causing vasoconstriction and triggering aldosterone.

24
New cards

ACE Inhibitors

Mechanism: Inhibit ACE to decrease Angiotensin II levels; common side effects include cough and hyperkalemia.

25
New cards

Calcium Channel Blockers (CCB)

Mechanism: Blocks calcium entry to reduce contraction force and dilate arteries; side effects may include hypotension and flushing.

26
New cards

Hypertension Medications and Heart Rate & Blood Pressure

Certain medications for hypertension can lower blood pressure while others may also lower heart rate. For example, ACE inhibitors primarily lower blood pressure, while beta-blockers lower both blood pressure and heart rate.

27
New cards

Beta-Blockers

This class of antihypertensives lowers both heart rate and blood pressure by blocking adrenaline receptors in the heart.

28
New cards

ACE Inhibitors

These medications lower blood pressure by inhibiting the production of Angiotensin II, but they do not directly reduce heart rate.

29
New cards

Calcium Channel Blockers (CCB)

These can lower blood pressure by relaxing blood vessels and may also reduce heart rate depending on the specific drug.

30
New cards

Thiazide Diuretics

While primarily used to lower blood pressure, thiazide diuretics do not significantly affect heart rate.

31
New cards

Lisinopril

An ACE inhibitor that helps lower blood pressure by inhibiting the production of Angiotensin II.

32
New cards

Atenolol

A beta-blocker that reduces heart rate and lowers blood pressure by blocking adrenaline effects on the heart.

33
New cards

Amlodipine

A calcium channel blocker that lowers blood pressure by relaxing blood vessels and may affect heart rate.

34
New cards

Hydrochlorothiazide

A thiazide diuretic that primarily lowers blood pressure without significantly affecting heart rate.

35
New cards

Losartan

An Angiotensin II receptor blocker that prevents the action of Angiotensin II, helping to reduce blood pressure.